The Center for Safe Internet Pharmacies’ blog profiles efforts to address the growing problem of consumer access to illegitimate pharmaceutical products on the Internet from the perspective of CSIP staff and board members and partners. It is updated on a a regular basis with new information and breaking news stories so be sure to check back often.
This spring, CSIP worked closely with our members Meta and Google to proactively extend the reach of the U.S. Drug Enforcement Agency (DEA)’s National Prescription Drug Take Back Day through a public service ad campaign that reached over 1.1 million users on the Facebook platform. CSIP has run similar successful campaigns in the past, but this is the first time that the effort has reached this milestone on a single platform.
A November 2021 article in The Washington Post reported a grim milestone in the ongoing overdose crisis that has been exacerbated during the nearly two-year COVID-19 pandemic: Between April 2020 and April 2021, the federal government counted over 100,000 deaths from overdoses. That is 275 people each day.
In light of these staggering numbers, U.S. consumers need resources to help them verify that their medicines – especially those purchased online – come from a safe source. Furthermore, they will benefit from vetted information about preventing prescription medicine misuse. This past autumn, CSIP and its members implemented two targeted campaigns aimed at addressing these important needs. Read More
As we mark the first half of 2021 complete, there were some important developments in efforts to combat the opioid epidemic in the United States. There were also additional positive accomplishments in areas related to treatment and care for those in recovery. Read More